Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm per Ghayas C. Issa, Courtney D. DiNardo

Obtenir text complet

A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults per R. Bou Serhal, P. Salameh, N. Wakim, C. Issa, B. Kassem, L. Abou Jaoude, N. Saleh

Obtenir text complet

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia per Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

Obtenir text complet

Management of chronic myeloid leukemia in 2023 – common ground and common sense per Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian

Obtenir text complet

REUSING STOCKS SOLUTIONS WITH DIFFERENT FORMULATED FOR ORCHID FERTILIZER ACCLIMATIZATION PHASE per C. G. C. Issa, W. J. Pereira, A. C. F. Miranda, R. C. Felicio, A. R. Silva, M. C. Vieira

Obtenir text complet

Reusing stocks solutions with different formulated for orchid fertilizer acclimatization phase per C. G. C. Issa, W. J. Pereira, A. C. F. Miranda, R. C. Felicio, A. R. Silva, M. C. Vieira

Obtenir text complet

Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series per Jennifer Marvin-Peek, Koji Sasaki, Dimitrios P. Kontoyiannis, Javier Adachi, Maro Ohanian, Koichi Takahashi, Ghayas C. Issa, Steven Kornblau, Hussein A. Abbas, Hussein A. Abbas

Obtenir text complet

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation per Matthew P. Cheng, Alisha Pandit, Joseph H. Antin, Stephen R. Walsh, Daisy Huynh, Irene M. Ghobrial, Lindsey R. Baden, Francisco M. Marty, Nicolas C. Issa

Obtenir text complet

Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia per Iman Abou Dalle, Ronald Paranal, Jabra Zarka, Shilpa Paul, Koji Sasaki, Wen Li, Jing Ning, Nicholas J. Short, Maro Ohanian, Jorge E. Cortes, Elias J. Jabbour, Ghayas C. Issa

Obtenir text complet

Calibration-free NGS quantitation of mutations below 0.01% VAF per Peng Dai, Lucia Ruojia Wu, Sherry Xi Chen, Michael Xiangjiang Wang, Lauren Yuxuan Cheng, Jinny Xuemeng Zhang, Pengying Hao, Weijie Yao, Jabra Zarka, Ghayas C. Issa, Lawrence Kwong, David Yu Zhang

Obtenir text complet

Myeloid lineage switch in <i>KMT2A-</i>rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies per Alex Bataller, Tareq Abuasab, David McCall, Wei Wang, Branko Cuglievan, Ghayas C. Issa, Elias Jabbour, Nicholas Short, Courtney D. DiNardo, Guilin Tang, Guillermo Garcia-Manero, Hagop M. Kantarjian, Koji Sasaki

Obtenir text complet

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE per Jeffrey Rubnitz, Ghayas C. Issa, Eytan M. Stein, Neerav Shukla, Wendy Stock, Andrius Žučenka, Sajad Khazal, Nandita Khera, Elliot Stieglitz, Jeremy Rubinstein, Galit Rosen, Rachel Ghiraldi, Huy Van Nguyen, Nicole Mcneer, C. Michel Zwaan

Obtenir text complet

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series per Ahmad S. Alotaibi, Musa Yilmaz, Sanam Loghavi, Courtney DiNardo, Gautam Borthakur, Tapan M. Kadia, Beenu Thakral, Naveen Pemmaraju, Ghayas C. Issa, Marina Konopleva, Nicholas J. Short, Keyur Patel, Guilin Tang, Farhad Ravandi, Naval Daver

Obtenir text complet

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience per Kamal Chamoun, Hagop Kantarjian, Rami Atallah, Graciela Nogueras Gonzalez, Ghayas C. Issa, Mary Beth Rios, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Nitin Jain, Naval Daver, Marina Konopleva, Courtney D. DiNardo, Tapan Kadia, Naveen Pemmaraju, Elias Jabbour, Jorge Cortes

Obtenir text complet

P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA per J. Senapati, J. Ishizawa, H. A. Abbas, S. Loghavi, G. Borthakur, G. C. Issa, S. I. Dara, R. Pourebrahim, N. Daver, E. J. Jabbour, S. M. Kornblau, N. Pemmaraju, G. Garcia-Manero, F. Ravandi, M. Muftuoglu, J. Khoury, C. DiNardo, M. Andreeff

Obtenir text complet

Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy per Wei-Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short

Obtenir text complet

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements per Ghayas C. Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas J. Short, Fadi Haddad, Zhenya Tang, Keyur P. Patel, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Farhad Ravandi

Obtenir text complet

P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM CELL TRANSPLANT (SCT) OUTCOMES IN OLDER ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) per F. Ong, F. Ravandi, U. Popat, T. M. Kadia, N. Daver, C. DiNardo, M. Konopleva, G. Borthakur, E. J. Shpall, B. Oran, G. Al-Atrash, R. Mehta, E. J. Jabbour, M. Yilmaz, G. C. Issa, G. Garcia-Manero, A. Maiti, H. A. Abbas, R. E. Champlin, N. J. Short

Obtenir text complet

Outcomes and genetic dynamics of acute myeloid leukemia at first relapse per Alex Bataller, Hagop Kantarjian, Alexandre Bazinet, Tapan Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Keyur Patel, Guilin Tang, Koji Sasaki, Nicholas J. Short, Musa Yilmaz, Ghayas C. Issa, Yesid Alvarado, Guillermo Montalban-Bravo, Abhishek Maiti, Hussein A. Abbas, Koichi Takahashi, Sherry Pierce, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi

Obtenir text complet

Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure per Nicholas J. Short, Sangeetha Venugopal, Wei Qiao, Tapan M. Kadia, Farhad Ravandi, Walid Macaron, Courtney D. Dinardo, Naval Daver, Marina Konopleva, Gautam Borthakur, Elizabeth J. Shpall, Uday Popat, Richard E. Champlin, Rohtesh Mehta, Gheath Al-Atrash, Betul Oran, Elias Jabbour, Guillermo Garcia-Manero, Ghayas C. Issa, Guillermo Montalban-Bravo, Musa Yilmaz, Abhishek Maiti, Hagop Kantarjian

Obtenir text complet